REPATRIATION MEDICAL AUTHORITY
INSTRUMENT NO. 57 OF 2011
VETERANS’ ENTITLEMENTS ACT 1986
MILITARY REHABILITATION AND COMPENSATION ACT 2004
EXPLANATORY NOTES FOR TABLING
- The Repatriation Medical Authority (the Authority) has determined, under subsection 196B(2) & (8) of the Veterans’ Entitlements Act 1986 (the VEA) Statement of Principles Instrument No. 57 of 2011.
2. This Instrument amends Statement of Principles Instrument No. 21 of 2009 concerning malignant neoplasm of the cerebral meninges by:
- Replacing existing factor 6(a) with a factor concerning 'ionising radiation';
- Deleting existing factor 6(b) as it is now subsumed by new factor 6(a);
- Re-numbering existing factor 6(c) as 6(b);
- Replacing the existing clause 7 to reflect the changes to the factors;
- Replacing the existing definition of "cumulative equivalent dose" in clause 9; and
- Deleting the definitions of "a course of therapeutic radiation" and "atomic radiation" from clause 9.
3. This Instrument also specifies a date of effect for the amendment in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.
4. Prior to determining this Instrument, the Authority advertised its intention to undertake an investigation in relation to malignant neoplasm of the cerebral meninges in the Government Notices Gazettes of 1 September 2010 and 3 November 2010, and circulated a copy of the notices of intention to investigate to a wide range of organisations representing veterans, service personnel and their dependants. The Authority invited submissions from the Repatriation Commission, organisations and persons referred to in section 196E of the VEA, and any person having expertise in the field. No submissions were received for consideration by the Authority during the investigation.
5. The determining of this Instrument finalises the investigation in relation to malignant neoplasm of the cerebral meninges as advertised in the Government Notices Gazettes of 1 September 2010 and 3 November 2010.
6. A list of references relating to the above condition is available to any person or organisation referred to in subsection 196E(1)(a) to (c) of the VEA. Any such request must be made in writing to the Repatriation Medical Authority at the following address:
The Registrar
Repatriation Medical Authority Secretariat
GPO Box 1014
BRISBANE QLD 4001
Overview
The Repatriation Medical Authority Instrument No. 57 of 2011 amends the Veterans' Entitlements Act 1986 by modifying the Statement of Principles concerning malignant neoplasm of the cerebral meninges. This legislative instrument was enacted to address issues related to the causation and recognition of malignant neoplasm of the cerebral meninges in veterans, specifically focusing on exposure to ionising radiation. The Authority was tasked with reviewing and updating the existing factors and definitions to better reflect current medical understanding and to ensure accurate and fair assessment of claims. The Repatriation Medical Authority undertook an investigation into this matter, advertising their intentions and inviting submissions from relevant stakeholders, although none were received. This Instrument concludes the investigation process and provides updated criteria for the recognition of this condition, ensuring that the legislation remains relevant and effective in addressing the needs of affected veterans.
Scope and Application
This instrument, Repatriation Medical Authority Instrument No. 57 of 2011, amends Statement of Principles Instrument No. 21 of 2009 concerning malignant neoplasm of the cerebral meninges under the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The instrument applies to veterans and service personnel, particularly those affected by malignant neoplasm of the cerebral meninges, and their dependants, thereby affecting their eligibility and entitlement to benefits and compensation. The instrument replaces and renumbers specific factors related to ionising radiation and removes certain definitions, finalising an investigation into the condition that was publicly advertised in the Government Notices Gazettes of 1 September 2010 and 3 November 2010. The changes are applicable nationally in Australia, with the Repatriation Medical Authority having the jurisdiction to determine these amendments. The instrument does not specify any exclusions, exemptions, or thresholds, but it does outline the process for requesting a list of references related to the condition from the Repatriation Medical Authority.
Key Provisions
The main operative sections of the Repatriation Medical Authority Instrument No. 57 of 2011 under the Veterans' Entitlements Act 1986 and Military Rehabilitation and Compensation Act 2004 involve amendments to Statement of Principles Instrument No. 21 of 2009 concerning malignant neoplasm of the cerebral meninges. Section 2 of the Instrument replaces existing factor 6(a) with a new factor relating to 'ionising radiation', deletes factor 6(b) as it is now subsumed by the new factor 6(a), re-numbers factor 6(c) to 6(b), and updates clause 7 to reflect these changes. It also replaces the existing definition of 'cumulative equivalent dose' in clause 9 and removes the definitions of 'a course of therapeutic radiation' and 'atomic radiation' from clause 9. The Instrument specifies an effective date for these amendments in accordance with subsection 12(1)(a) of the Legislative Instruments Act 2003.
The Repatriation Medical Authority, in determining this Instrument, imposed several obligations on the relevant parties. It advertised its intention to investigate malignant neoplasm of the cerebral meninges in the Government Notices Gazettes on 1 September 2010 and 3 November 2010. Additionally, it circulated notices of the investigation to a wide range of organisations representing veterans, service personnel, and their dependants. The Authority invited submissions from the Repatriation Commission, organisations, and individuals referred to in section 196E of the VEA, as well as any person with expertise in the field. Despite these efforts, no submissions were received for consideration during the investigation.
In terms of consequences for breach, the Instrument does not explicitly detail offences, penalties, or specific civil or criminal consequences for non-compliance. However, as a legislative instrument, it is subject to the general legal framework in which it operates. Failure to adhere to the provisions of the Instrument could potentially lead to disputes or challenges under the applicable Acts, including the Veterans’ Entitlements Act 1986 and the Military Rehabilitation and Compensation Act 2004. The Authority's decisions are also subject to review under the Administrative Decisions (Judicial Review) Act 1977. The penalties or outcomes of such reviews would depend on the specific circumstances of any non-compliance or dispute.